Previous close | 1.2000 |
Open | 1.2000 |
Bid | 1.0000 |
Ask | 2.5500 |
Strike | 17.50 |
Expiry date | 2024-10-18 |
Day's range | 1.2000 - 1.2000 |
Contract range | N/A |
Volume | |
Open interest | 3 |
When you buy shares in a company, there is always a risk that the price drops to zero. But if you pick the right...
PLANEGG/MUNICH, Germany, April 29, 2024--MorphoSys AG (FSE: MOR; NASDAQ: MOR) reports results for the first quarter of 2024.
Novartis (NVS) enters into a license deal with Arvinas, Inc. (ARVN) for the worldwide development and commercialization of cancer candidate ARV-766. Shares of ARVN rise on the news.